Venous thromboembolism in adults

the capacity to carry out the reviews and to review and update the information, advice and support given to people when they started having anticoagulation treatment. People aged 18 and over who have had a blood clot and are taking an anticoagulant (medicine to prevent another blood clot) have a review at 3 months to discuss whether to continue or stop taking the anticoagulant, or change to a different anticoagulant. If they continue the anticoagulant, they have a review at least once a year. The information, advice and support they were given when they started having anticoagulation treatment is reviewed and updated, and they are also given information about when their treatment reviews will be scheduled. Source guidance Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline NG158 (2020, updated 2023), recommendations 1.4.1 and 1.4.12 Definitions of terms used in this quality statement Review at 3 months A review after 3 months of anticoagulation treatment to assess and discuss the benefits and risks of continuing, stopping or changing the anticoagulant with the person having treatment, and to review and update the information, advice and support given when they started having anticoagulation treatment. [Adapted from NICE's guideline on venous thromboembolic
